Delivery Order SPE2DB25D3020-SPE2DB25FWGDS
Award Date
2/27/25
Potential Completion Date
2/28/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product Ozempic, a diabetes medication, with a ceiling value of $3,127.39. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type, with an ultimate completion date of November 27, 2024. The contract was not set aside for any specific business...
This federal contract award is for the delivery of the pharmaceutical product Ozempic, a diabetes medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that the company holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
This federal contract award is for the procurement of Ozempic, a medication used to treat diabetes, with a ceiling value of $10,074.09. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of October 21, 2024. The contract does not have a set-aside designation, indicating open competition. This...
This federal contract award is for the delivery of Ozempic, a medication used to treat diabetes, to the Defense Logistics Agency (DLA). The prime contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The contract, valued at $6,487.57, has a completion date of December 14, 2023 and is a firm fixed-price delivery order. This award is part of a larger...
This federal contract award is for the pharmaceutical product Ozempic, a treatment used for diabetes management. The contract, valued at $20,077.82, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award is for the delivery of Ozempic, a medication used for diabetes management, to the Defense Logistics Agency (DLA) Troop Support Medical. The $34,921.31 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 27, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Ozempic, a medication used for the treatment of diabetes, to support military healthcare programs. The contract, valued at $2,612.36, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 22, 2024, with a ceiling value of $1,084.03 and a completion date of November 25, 2024. This is a delivery order contract, with a firm fixed price pricing type. The contract is not designated with a set-aside...
This federal contract award is for the delivery of the pharmaceutical product Ozempic, a 2 mg/dose medication used to treat diabetes. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $131,643.50, and an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Ozempic, a medication used to treat type 2 diabetes, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $10,055.07, and has an ultimate completion date of March 19, 2024. The contract is not designated with a set-aside requirement, indicating open competition....